RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model
Show full item record

This item appears in the following Collection(s)


Search Deep Blue

Advanced Search

Browse by

My Account

Information

Coming Soon


MLibrary logo